Addressing the criterias that VCs look for when investing in early start up companies at the Pharma Partnering & Investments 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012, is Mr Goro Takeda.
Mr Goro leads his team on identifying Life Science spin-out opportunities in Asia. He was also involved with investments in biotechnology and specialty pharmaceutical companies including Arrow Therapeutics, Cyclacel Pharmaceuticals and Plexxikon.
Mr Goro will be sharing on the following:
Recognizing the criteria that VCs look for when investing in small startup companies
1. Assessing risks and returns in investing in startup companies
2. Understanding the therapeutic fields that attract VCs
3. Developing stringent evaluation criteria and performing in-depth due diligence